Introduction {#Sec1}
============

The disease caused by the virus named as SARS-CoV-2 started in Wuhan, China at the end of 2019. It spread throughout the globe at an alarming pace and became the first pandemic of the twenty-first century. After seeing some signs of slowing with worldwide measures, it is evident that the disease (COVID-19) will continue to spread due to the reduction in strict measures \[[@CR1]\].

It is well-established that the disease may be asymptomatic or may range from mild to very severe symptoms \[[@CR2]--[@CR4]\]. According to the data obtained in recent studies, the severity of the disease differs epidemiologically according to race, gender and age \[[@CR2], [@CR5], [@CR6]\].

COVID-19 was classified as type A has seen in the USA and Australia, type B has seen in China, and East Asia and type C has seen in Europe in a recent study \[[@CR7]\]. These subtypes can have different clinical symptoms as well.

In this study, we aimed to investigate otolaryngological symptoms in patients diagnosed with COVID-19 at our clinic.

Methods {#Sec2}
=======

We conducted a retrospective observational study in our hospital which was designated as a 'pandemic hospital' by the Ministry of Health, between March 25, 2020 and April 25, 2020. The study group was comprised of patients who had applied to our outpatient clinic and were later confirmed to have COVID-19 via real-time PCR (qRT-PCR) tests on respiratory samples (oropharyngeal and nasopharyngeal swabs). All patients between the ages of 18--72 were included in the study. The patient groups with otolaryngological symptoms were divided into 5 age groups: ages between 18--30 was defined as Group 1, ages between 30--40 was Group2, ages between 50--60 was Group 4 and ages more than 60 was defined as Group 5. The distribution of age according to ENT symptoms was evaluated. The extraction of RNA from samples was performed using the NucleoSpin^®^ RNA Virus kit (Macherey--Nagel) according to the manufacturer's instructions, and amplification via RT-PCR was performed with protocols developed by the Turkish National Public Health Institute \[[@CR8]\].

We aimed to determine the frequency of various otolaryngologic symptoms in patients with COVID-19, and to evaluate these symptoms with regard to age, gender and thorax CT results.

Every patient who applied to our outpatient clinic first went through nurse triage. Body temperature (Medisana Thermometer 48,611), pulse and saturation (WristOx2 3150 Nonin Medical pulse oximeter) values of each patient who applied to our outpatient clinic were routinely measured and recorded by nurses before being subject to clinical examination by a physician. The oxygen saturations of the patients were also compared in this study. Then, the patients were given a two-page form to fill their medical history and complaints. (The language used in the form was easily understandable.) Any patients who had difficulty in filling the form were guided by nurses and physicians who provided explanatory support without leading or rushing the patients. In this form, the patients were first asked about the presence of additional diseases, allergies, use of alcohol or smoking, medications and any previous surgical history. In the next section of the form, detailed complaints were given in an easy to understand language with subheadings, including symptoms of the head and neck region, cardiovascular system, respiratory system, gastrointestinal system, genitourinary system, central nervous system and musculoskeletal system, and dermatological findings. The patients were asked to simply mark the complaints that they were experiencing at the time. The head and neck region complaints included the following: loss of odor and/or taste, sore throat, cough, nasal congestion, postnasal discharge, otalgia, tinnitus, hearing loss, oro-dental problems, vertigo, hoarseness and any other additional complaints. The patients were asked to simply mark all complaints that they were currently experiencing.

Detailed anamnesis, age, gender, follow-up studies, possible consultations with the infectious diseases and chest diseases departments, blood analysis results, tomography and PCR results were obtained from the electronic database of the hospital and Ministry of Health. All obtained results were examined in the current study.

This retrospective, archival, and the clinical study was conducted in line with the dictates of the World Medical Association Declaration of Helsinki with the informed consent of the participants and was approved by the local ethical committee.

Microsoft Excel and SPSS (Statistical Package for Social Sciences) Release 22.0 were used to evaluate the data. For all parameters, *p* ≤ 0.05 was considered statistically significant. Statistics for all data were presented as mean ± standard deviation, number and percentages. Fisher's exact and Chi square tests were used in comparisons of categorical data.

Results {#Sec3}
=======

There were otolaryngological symptoms in 89 (57.4%) of 155 patients. Of these 89 patients, 55(35.4%) had anosmia, 25 (16.1%) had ageusia, 42 (27%) had sore throat, 68 (43.8%) had cough, 20 (12.9%) had nasal congestion, 10 (6%) had postnasal discharge, 4 (2%) had otalgia, 15 (9%) had runny nose, 2 (1.2%) tinnitus, 8 (5.1%) hoarseness, 2 (1.2%) had gingivitis, 1 (0.6%) had Bell's palsy, 1 (0.6%) had sudden hearing loss problems (Table [1](#Tab1){ref-type="table"}).Table 1Numbers and percentages of ENT symptoms in COVID-19 disease PCR positivepatientsENT symptoms*N* (%)Cough68 (43.8)Anosmia55 (35.4)Sorethroat42 (27)Ageusia25 (16.1)Nasalcongestion20 (12.9)Runnynose15 (9)Postnasaldischarge10 (6)Hoarseness8 (5.1)Otalgia4 (2)Tinnitus2 (1.2)Gingivitis2 (1.2)Bell's palsy1 (0.6)Suddenhearingloss1 (0.6)

Ninety-one (58.7%) of the 155 patients were female, and 64 (42.2%) were male. Otolaryngologic (ENT) symptoms were seen at a higher frequency in females compared to males (*p*: 0.029) (Table [2](#Tab2){ref-type="table"}).Table 2Distribution of gender according to ENT symptoms in COVID-19 disease PCR positive patientsDistribution of genderENT symptoms + ENT symptoms − Total*P* value(*n*)(*n*)(*n*)Female5437910.029\*\*Male3529640.623Total8966155\*\*Statistically significant

Overall, 64 of the patients were hospitalized, while 91 were quarantined at home. Hospitalization criteria routinely included the presence of ground glass appearance in CT and conclusive findings of pneumonia. Other factors that were considered in the decision for hospitalization were: severe vomiting, resistant diarrhea, dyspnea, and progressive/resistant fever according to recent Ministry of Health guidelines.

When the comorbidities of the patients were examined, 28 hypertension (18%), 21 asthma (13.5%), 14 cardiovascular diseases (9.6%), chronic obstructive pulmonary disease 8 (5.1%), and other comorbid diseases were observed less frequently.

The average age of the group was 36.3 ± 8.1 years. When patient groups with otolaryngological symptoms were divided into 5 age groups, it was revealed that the ENT symptoms were mostly observed in the 18--30 years age group (*p*: 0.013) (Table [3](#Tab3){ref-type="table"}).Table 3Distribution of age according to ENT symptoms in COVID-19 disease PCR positive patientsDistribution of ageENT symptoms + ENT symptoms − *P* value(*n*)(*n*)Group 1 Age 18--302590.013\*\*Group2 Age 30--4018150.678Group3 Age 40--5019140.579Group4 Age 50--6016150.882Group5 Age \> 6011130.568Total8966\*\*Statistically significant

Fifty-eight (37.4%) patients received a clinical diagnosis of pneumonia and had ground glass in tomography. There was no statistical difference in the frequency of pneumonia among COVID-19 patients with or without ENT symptoms (Table [4](#Tab4){ref-type="table"}).Table 4Distribution of results of thorax CTs, and pneumonia according to ENT symptoms in COVID-19 disease PCR positive patientsResults of Thorax CTs and pneumoniaENT symptoms + ENT symptoms − Total*P* value(*n*)(*n*)Pneumonia positive thorax CT results3028580.875Pneumonia negative thorax CT results5938970.572Total8966155

The patients' oxygen saturation was 95.8% (± 3.2). There was no statistical significance in the saturations of patients with or without ENT symptoms (*p*: 0.85).

Discussion {#Sec4}
==========

COVID-19 disease is a new pandemic that occurs towards the end of 2019. Information about this disease was shared by China first, and then more information about the disease was obtained with its spread throughout Europe, especially Italy. However, since this pandemic is new, information about this disease is also limited.

Knowing the symptoms and percentages of the disease will help to discover COVID-19 disease more, and create more effective treatment protocols. There are recent general symptom studies on this topic. However, to our knowledge, detailed research on ENT symptoms is still more limited. Studies on COVID-19 revealed that ENT symptoms were observed more frequently in younger age groups, and women \[[@CR9]--[@CR11]\].

In general, studies on COVID symptoms indicate fatigue, cough, headache, fever, myalgia, arthralgia, and diarrhea \[[@CR4], [@CR12]\]. In our study, the symptoms of ENT were examined in more detail, and the highest percentage of ENT was cough (43.8%), and sore throat, and anosmia (35.4%). Unlike our study, Yonghyun et al. found anosmia in 15.3% of their patient group \[[@CR13]\]. Based on our study, we can say the most significant predictive otolaryngologic symptoms are cough, anosmia, and sore throat.

In addition to the literature, the least common ENT symptoms were tinnitus in two patients, hoarseness in eight, and gingivitis in two patients. It is not known whether they are symptomatic of the disease or seen as an incidentally additive to the disease.

Of the 155 patients admitted to our outpatient hospital, 58 (37.4%) of them had ground glass appearance with pneumonia, and according to our government ministry of health care agency's hospitalization algorithm, these patients were hospitalized. In other studies, this rate was found at 29.2% \[[@CR12]\]. Two of our patients were taken to the intensive care unit. These patients did not show any ENT symptoms.

The retrospective nature of our study may not reflect the actual population since it does not include inpatients, and is of only one origin. The lack of knowledge of how the symptoms persist, the results of the treatment they receive create the limitations of our research. However, as far as it is known, the studies performed as isolated ENT symptoms on COVID-19 are limited. This study is the known first study in the literature that provides information on ENT symptoms, and age, gender, and pneumonia critters.

Currently, many hospitals in many countries around the world are working as pandemic quarantine hospitals, but as the number of COVID patients decreases, the measures taken are further relaxed, and the numbers of quarantine hospitals are decreasing for the current situation.

In this process, in which patient examination is increased with other diseases other than COVID-19 disease, it is recommended that ENT doctors and family physicians have an idea, and be more careful about these various symptoms of patients.
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